Copper Promoted 8-Aminoimidazo[1,2-a]pyridine-Directed Additive-Free Ortho C(sp2)–H C–S, C–Se Functionalization of (Hetero)Arenes
Synthesis · 01.03.2026 · 58 (05) · 497-510
DOI: 10.1055/a-2755-9816 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthesis, erschienen am 01.03.2026. Verfasst von Priyadarshi Manna und 3 weiteren Autor:innen. Die Arbeit nennt 88 Literaturangaben.
Abstract (Originalsprache)
Diaryl sulfides, diaryl selenides, and their derivatives are crucial scaffolds in the fields of organic chemistry and drug discovery. We report a practical and broadly applicable strategy for additive-free copper(II)-catalyzed ortho-sulfanylation and selanylation of β-C(sp2)–H bonds in (hetero)arenes, directed by 8-aminoimidazo[1,2-a]pyridine (8-AIP), a removable 6,5-fused bicyclic N,N-bidentate directing group. This protocol features mild reaction conditions that enable the formation of diverse functionalized thioethers and selenides using thiols, disulfides, and diselenides, with enhanced functional group tolerance and unique site-selectivity. The present protocol is reproducible in gram scale, and, in addition, we have also the showed cleavage of chelating auxiliary.
Zitieren
APA
Manna, P., Mukherjee, R., Kundu, M., & Adhikari, S. S. (2026). Copper Promoted 8-Aminoimidazo[1,2-a]pyridine-Directed Additive-Free Ortho C(sp2)–H C–S, C–Se Functionalization of (Hetero)Arenes. Synthesis, 58(05), 497-510. https://doi.org/10.1055/a-2755-9816
Vancouver
Manna P, Mukherjee R, Kundu M, Adhikari SS. Copper Promoted 8-Aminoimidazo[1,2-a]pyridine-Directed Additive-Free Ortho C(sp2)–H C–S, C–Se Functionalization of (Hetero)Arenes. Synthesis. 2026;58(05):497-510. doi:10.1055/a-2755-9816
BibTeX
@article{Manna2026,
author = {Manna, Priyadarshi and Mukherjee, Rusmita and Kundu, Mrinalkanti and Adhikari, Susanta Sekhar},
title = {Copper Promoted 8-Aminoimidazo[1,2-a]pyridine-Directed Additive-Free Ortho C(sp2)–H C–S, C–Se Functionalization of (Hetero)Arenes},
journal = {Synthesis},
year = {2026},
volume = {58},
number = {05},
pages = {497--510},
doi = {10.1055/a-2755-9816}
}
EUVIMED